Citation: | ZHANG Fangrong, WANG Wei. Advances of synthetic lipoproteins as drug nanovectors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 148-157. DOI: 10.11665/j.issn.1000-5048.20160204 |
[1] |
Zhang L,Song J,Cavigiolio G,et al.Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy[J].J Lipid Res,2011,52(1):175-184.
|
[2] |
Wang RN,Liu CY,Zhou JP,et al.Advanced in the research of lipoprotein-based nanoscale drug delivery systems[J].J China Pharm Univ(中国药科大学学报),2014,45(1):10-16.
|
[3] |
Sabnis N,Lacko AG.Drug delivery via lipoprotein-based carriers:answering the challenges in systemic therapeutics[J].Therapeutic Deliv,2012,3(5):599-608.
|
[4] |
Zhang Z,Chen J,Ding L,et al.HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting[J].Small,2010,6(3):430-437.
|
[5] |
Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer[J].Nat Rev Drug Discov 2008,7(9):771-782.
|
[6] |
Dieckmann M, Dietrich MF, Herz J. Lipoprotein receptors—an evolutionarily ancient multifunctional receptor family[J].J Biol Chem,2010,391(11):1341-1363.
|
[7] |
Danilo C, Gutierrez-Pajares JL, Mainieri MA, et al. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development[J].Breast Cancer Res,2013,15(5):R87.
|
[8] |
Twiddy AL, Cox ME, Wasan KM. Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells[J].Prostate,2012,72(9):955-965.
|
[9] |
Narasimhan K,Pillay S,Bin Ahmad NR,et al.Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2[J].ACS Chem Biol,2011,6(6):573-581.
|
[10] |
Guo D,Reinitz F,Youssef M,et al.An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway[J].Cancer Discov,2011,1(5):442-456.
|
[11] |
Leon CG,Locke JA,Adomat HH,et al.Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model[J].Prostate,2010,70(4):390-400.
|
[12] |
Zheng Y,Liu Y,Jin H,et al.Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles[J].Theranostics,2013,3(7):477.
|
[13] |
Qiu Y,Liu S,Chen H T,et al.Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease[J].Hepatobiliary Pancreat Dis Int,2013,12(6):630-636.
|
[14] |
Liu KH,Wang CP,Chang MF,et al.Molecular characterization of photosensitizer-mediated photodynamic therapy by gene expression profiling[J].Hum Exp Toxicol,2014,33(6):629-637.
|
[15] |
Mökelö KM, Traylor M, Oksala N, et al. Association of the novel single-nucleotide polymorphism which increases oxidized low-density lipoprotein levels with cerebrovascular disease events[J].Atherosclerosis,2014,234(1):214-217.
|
[16] |
Lu T,Wen S,Cui Y,et al.Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome[J].Int J Cardiovasc Imaging,2014,30(1):221-231.
|
[17] |
Gordts SC,Singh N,Muthuramu I,et al.Pleiotropic effects of HDL:towards new therapeutic areas for HDL-targeted interventions[J].Curr Mol Med,2014,14(4):481-503.
|
[18] |
Krieger M,Anderson RGW,Goldstein JL,et al.Reconstituted low density lipoprotein:a vehicle for the delivery of hydrophobic fluorescent probes to cells[J].J Supramol Struct,1979,10(4):467-478.
|
[19] |
Vesell ES.Advances in pharmacogenetics and pharmacogenomics[J].J Clin Pharmacol,2000,40(9):930-938.
|
[20] |
Kader A,Pater A.Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells[J].J Controlled Release,2002,80(1):29-44.
|
[21] |
Yang M,Jin H,Chen J,et al.Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles[J].Small,2011,7(5):568-573.
|
[22] |
Lin Q,Chen J,Ng KK,et al.Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles[J].Pharm Res,2014,31(6):1438-1449.
|
[23] |
Jin H,Lovell JF,Chen J,et al.Mechanistic insights into LDL nanoparticle-mediated siRNA delivery[J].Bioconjug Chem,2011,23(1):33-41.
|
[24] |
Walsh MT,Atkinson D.Solubilization of low-density lipoprotein with sodium deoxycholate and recombination of apoprotein B with dimyristoylphosphatidylcholine[J].Biochemistry,1983,22(13):3170-3178.
|
[25] |
Ginsburg GS,Walsh MT,Small DM,et al.Reassembled plasma low density lipoproteins.Phospholipid-cholesterol ester-apoprotein B complexes[J].J Biol Chem,1984,259(10):6667-6673.
|
[26] |
Lundberg B.Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway[J].Cancer Res,1987,47(15):4105-4108.
|
[27] |
Vogel T,Weisgraber KH,Zeevi MI,et al.Human apolipoprotein E expression in Escherichia coli:structural and functional identity of the bacterially produced protein with plasma apolipoprotein E[J].Proc Natl Acad Sci,1985,82(24):8696-8700.
|
[28] |
Esatbeyoglu T, Ulbrich K, Rehberg C, et al. Thermal stability,antioxidant,and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol[J].Food Funct,2015,6(3):887-893.
|
[29] |
Zhu Q,Zhou Y,Guan M,et al.Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy[J].Biomaterials, 2014,35(22):5965-5976.
|
[30] |
Taratula O,Schumann C,Duong T,et al.Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy[J].Nanoscale,2015,7(9):3888-3902.
|
[31] |
Marotta DE,Cao W,Wileyto EP,et al.Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo[J].Nanomedicine,2011,6(3):475-487.
|
[32] |
Corbin IR,Li H,Chen J,et al.Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents[J].Neoplasia,2006,8(6):488-498.
|
[33] |
Allijn IE,Leong W,Tang J,et al.Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level[J].ACS Nano,2013,7(11):9761-9770.
|
[34] |
Zheng G,Chen J,Li H,et al.Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents[J].Proc Natl Acad Sci U S A,2005,102(49):17757-17762.
|
[35] |
Bricarello DA,Smilowitz JT,Zivkovic AM,et al.Reconstituted lipoprotein:a versatile class of biologically-inspired nanostructures[J].ACS Nano,2010,5(1):42-57.
|
[36] |
Mooberry LK,Nair M,Paranjape S,et al.Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier[J].J Drug Target, 2010,18(1):53-58.
|
[37] |
Shahzad MMK,Mangala LS,Han HD,et al.Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles[J].Neoplasia,2011,13(4):309-319.
|
[38] |
Liu CY, Wang W, Zhou JP, et al.Preparation and evaluation of gambogic acid loaded reconstituted high density lipoprotein nanoparticles[J].J China Pharm Univ(中国药科大学学报),2013,44(4):311-315.
|
[39] |
Sabnis N,Pratap S,Akopova I,et al.Pre-clinical evaluation of rHDL encapsulated retinoids for the treatment of neuroblastoma[J].Front Pediatr,2013,3:1-6.
|
[40] |
Ding Y,Wang W,Feng M,et al.A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy[J].Biomaterials,2012,33(34):8893-8905.
|
[41] |
Sabnis N,Nair M,Israel M,et al.Enhanced solubility and functionality of valrubicin(AD-32)against cancer cells upon encapsulation into biocompatible nanoparticles[J].Int J Nanomedicine,2012,7:975.
|
[42] |
Thaxton CS,Daniel WL,Giljohann DA,et al.Templated spherical high density lipoprotein nanoparticles[J].J Am Chem Soc,2009,131(4):1384-1385.
|
[43] |
McMahon KM,Mutharasan RK,Tripathy S,et al.Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery[J].Nano Lett,2011,11(3):1208-1214.
|
[44] |
Ghosh M,Singh ATK,Xu W,et al.Curcumin nanodisks:formulation and characterization[J].Nanomedicine,2011,7(2):162-167.
|
[45] |
Singh ATK, Ghosh M, Forte TM, et al. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma[J].Leuk Lymphoma,2011,52(8):1537-1543.
|
[46] |
Ghosh M,Ryan R O.ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiformecells[J].Nanomedicine,2014,9(6):763-771.
|
[47] |
Ng KK,Lovell JF,Vedadi A,et al.Self-assembled porphyrinnanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications[J].ACS Nano,2013,7(4):3484-3490.
|
[48] |
Ghosh M,Ren G,Simonsen JB,et al.Cationic lipid nanodisks as an siRNA delivery vehicle[J].Biochem Cell Biol,2014,92(3):200-205.
|
[49] |
Duivenvoorden R, Tang J, Cormode DP, et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation[J].Nat Commun,2014,5:1661-1667
|
[50] |
Cho KH.Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration[J].J Gerontol A Biol Sci Med Sci,2011,66(12):1274-1285.
|
[51] |
Bhattacharya P,Grimme S,Ganesh B,et al.Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection[J].J Virol,2010,84(1):361-371.
|
[52] |
Song Q,Huang M,Yao L,et al.Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer′s disease by accelerating the clearance of amyloid-beta[J].ACS Nano,2014,8(3):2345-2359.
|
[53] |
Baillie G,Owens MD,Halbert GW.A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro[J].J Lipid Res,2002,43(1):69-73.
|
[54] |
Nikanjam M,Gibbs A R,Hunt C A,et al.Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme[J].J Control Release,2007,124(3):163-171.
|
[55] |
Huntosova V,Buzova D,Petrovajova D,et al.Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells[J].Int J Pharm,2012,436(1):463-471.
|
[56] |
Zhang Z,Cao W,Jin H,et al.Biomimetic nanocarrier for direct cytosolic drug delivery[J].Angew Chem Int Ed Engl,2009,48(48):9171-9175.
|
[57] |
Lin Q,Chen J,Ng KK,et al.Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles[J].Pharm Res,2014,31(6):1438-1449.
|
[58] |
Yang M,Chen J,Cao W,et al.Attenuation of nontargeted cell-kill using a high-density lipoprotein-mimicking peptide-phospholipid nanoscaffold[J].Nanomedicine,2011,6(4):631-641.
|
[59] |
Lin Q, Jin CS, Huang H, et al. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model[J].Small,2014,10(15):3072-3082.
|
[60] |
Handattu SP,Garber DW,Monroe CE,et al.Oral apolipoprotein AI mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer′s disease[J].Neurobiol Disease,2009,34(3):525-534.
|
[61] |
Yang S,Damiano MG,Zhang H,et al.Biomimetic,synthetic HDL nanostructures for lymphoma[J].Proc Natl Acad Sci,2013,110(7):2511-2516.
|
[62] |
Gomaraschi M,Calabresi L,Rossoni G,et al.Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein AI mimetic peptides[J].J Pharmacol Exp Ther,2008,324(2):776-783.
|
[63] |
Sigalov AB. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages[J].Contrast Media Mol Imaging,2014,9(5):372-382.
|
[64] |
Khumsupan P,Ramirez R,Khumsupan D,et al.Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein:ananovehicle to transport curcumin,an antioxidant and anti-amyloid bioflavonoid[J].Biochim Biophys Acta,2011,1808(1):352-359.
|
[1] | WANG Songkai, ZOU Yuchen, SUN Shipeng, YAN Zhiye, TANG Weiwei, LI Ping, LI Bin. Recent advances in mass spectrometry imaging and its application in drug research[J]. Journal of China Pharmaceutical University, 2023, 54(6): 653-661. DOI: 10.11665/j.issn.1000-5048.2023091901 |
[2] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[3] | ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403 |
[4] | WEI Yuanyuan, YANG Fan, TANG Jie, YU Lifang. Advances in the research of anti-tuberculosis drugs[J]. Journal of China Pharmaceutical University, 2020, 51(2): 231-239. DOI: 10.11665/j.issn.1000-5048.20200215 |
[5] | HAN Xiu, QI Xiaole, WU Zhenghong. Advances in self-assemblied DNA nanocages as drug delivery systems[J]. Journal of China Pharmaceutical University, 2017, 48(6): 663-669. DOI: 10.11665/j.issn.1000-5048.20170605 |
[6] | CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203 |
[7] | JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418 |
[8] | YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417 |
[9] | LIU Yanhong, ZHOU Jianping, HUO Meirong. Advances in the tumor microenvironment-responsive smart drug delivery nanosystem[J]. Journal of China Pharmaceutical University, 2016, 47(2): 125-133. DOI: 10.11665/j.issn.1000-5048.20160201 |
[10] | WANG Ruoning, LIU Congyan, ZHOU Jianping, CHEN Jian, WANG Wei. Advances in the research of lipoprotein-based nano scale drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(1): 10-16. DOI: 10.11665/j.issn.1000-5048.20140102 |